Decreased levels of XPO5 protein expression has been linked with a worst prognosis of renal and esophageal tumors, whereas a better prognosis has been seen in multiple myeloma, liver cancer and in non-small-cell lung cancer [104,105]. The gene discussed is XPO5; the disease is liver cancer.